In 2023, the European Union’s pharmaceutical exports reached a new milestone, supporting approximately 926,000 jobs across the bloc. This figure represents 4.3 per mille of

total EU employment—the highest level recorded to date—highlighting the growing importance of the sector in sustaining the region’s workforce.

The impact of pharmaceutical exports extends well beyond the industry itself. Of the total jobs supported, around 325,000 were directly employed within the pharmaceutical sector. Meanwhile, a significantly larger share—about 601,000 positions—was sustained indirectly across other industries, underlining the sector’s wide-reaching economic influence.

This marks a substantial increase compared with 2010, when pharmaceutical exports supported just over 504,000 jobs. Over the 13-year period, employment tied to these exports has nearly doubled, with its share of total EU employment rising from 2.6 per mille to 4.3 per mille.

A closer look at export destinations reveals that the United States remains the most significant partner, accounting for jobs held by around 275,000 EU workers in 2023. Switzerland and China follow closely, supporting 104,000 and 103,000 jobs respectively.

Other key markets include the United Kingdom and Japan, where exports underpin employment for 51,000 and 42,000 workers.

The steady rise in employment linked to pharmaceutical exports has been largely driven by strong demand from these major trade partners. The most notable growth since 2010 has come from the United States, with an increase of 147,000 jobs supported, followed by China (+91,000) and Switzerland (+38,000).

Overall, the data underscores the pharmaceutical sector’s expanding role as a key engine of employment in the European Union, driven by robust global demand and deepening trade ties. Photo by [1], Wikimedia commons.